Sterling Pharma Solutions

Dudley, United Kingdom Founded: 2016 • Age: 10 yrs Acquired By GHO Capital Partners
Contract development, manufacturing, and analytical services for APIs are offered.

About Sterling Pharma Solutions

Sterling Pharma Solutions is a Healthcare company based in Dudley (United Kingdom) founded in 2016, and was acquired by GHO Capital Partners in February 2019. Contract development, manufacturing, and analytical services for APIs are offered. Sterling Pharma Solutions has completed 3 acquisitions, including ADC Biotechnology, CiVentiChem and NewChem Technologies. Its chief executive, as recorded, is Kevin Cook. Its website sterlingpharmasolutions.com draws about 12 thousand monthly visits. Sterling Pharma Solutions offers products and services including API Development, API Manufacturing, ADC Development, Peptide Manufacturing, and Analytical Services. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production. Its legal entity is STERLING PHARMA SOLUTIONS LIMITED.

Company details

Sterling Pharma Solutions was established in 2016 in Dudley, United Kingdom. Operations focus on the pharmaceutical sector as a contract development and manufacturing organization (CDMO). Services encompass contract development, manufacturing, and analytical support specifically for active pharmaceutical ingredients (APIs). The company is led by CEO Kevin Cook and maintains its primary location in the UK to serve global clients in the industry.

Key Metrics

Products & Services of Sterling Pharma Solutions

Sterling Pharma Solutions offers a comprehensive portfolio of products and services, including API Development, API Manufacturing, ADC Development, Peptide Manufacturing, and Analytical Services.

API Development
Pharmaceutical Services

Services for API route scouting and process optimization.

API Manufacturing
Manufacturing

cGMP production of APIs including high-potency and hazardous compounds.

ADC Development
Bioconjugation

Support for ADC discovery, development, and clinical manufacturing.

Peptide Manufacturing
Biotech Services

Analysis, purification, and production of novel peptides.

Analytical Services
Testing

Techniques like mass spectrometry for drug molecule evaluation.

Apps and channels of Sterling Pharma Solutions

its YouTube channel Sterling Pharma Solutions has 225 subscribers and 30 videos.

Sterling Pharma Solutions
YouTube 225 subscribers 30 videos Science & Technology
Open channel

Videos from Sterling Pharma Solutions

The most watched videos on Sterling Pharma Solutions's YouTube channel, Sterling Pharma Solutions (225 subscribers). Click a video to play it here.

Facility overview - Deeside, UK - Sterling Pharma Solutions
12.8K views
Environmental sustainability in the pharmaceutical industry
5.5K views
Biocatalysis: Using enzymes as catalysts
2.8K views
Phase I ADC development and manufacturing: A case study
2.6K views

More on Sterling Pharma Solutions.

Funding Insights of Sterling Pharma Solutions

  • Total Rounds 1
  • Investors Count 2

All 1 funding rounds of Sterling Pharma Solutions with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2023Seed––
Valuation history

2 investors in total: 2 institutional.

Investors in Sterling Pharma Solutions

Sterling Pharma Solutions has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Partners Group and GHO Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Specialist healthcare investment advisory services are provided by GHO Capital.
ghocapital.comLondon, United Kingdom
Private equity funds are managed across multiple sectors globally.
1996partnersgroup.comBaar, Switzerland
Premium access

Investor details for Sterling Pharma Solutions

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Sterling Pharma Solutions

193 people are tracked at Sterling Pharma Solutions (61 in leadership, 132 in team).

NameRoleGroup
Kevin Cook
CEOLeadership
Anne O'Sullivan
People & Organisation Business PartnerLeadership
Karen Gallon
Head Of QualityLeadership
Andy Borthwick
Associate Director Facilities, Maintenance & IntegrationLeadership
Gary Chetcuti
Director Of OperationsLeadership
Ian Lisle
Global Head Of QualityLeadership
Vagn Pedersen
Associate Director Of Supply ChainLeadership
Dr Anupama S.
Director, Business DevelopmentLeadership
Adam Kujath
Executive Vice President & Site HeadLeadership
Paul Malone
Manufacturing HeadLeadership
Lauren Youmans
Human Resources Business PartnerLeadership
Alisha Arrigo
Business Development DirectorLeadership
Mathew Minardi
Executive Vice President Global Project ManagementLeadership
Tony Deehr
Director, EHSLeadership
Katie Crowley
Associate Director Of Project ManagementLeadership
Srinivas Battina
Associate DirectorLeadership
Matt Miklas
Associate Director, Technical ServicesLeadership
Niamh McDonnell
People And Organisation Business PartnerLeadership
Joseph Culloty
Head Of QualityLeadership
Helen Stephenson
Director Environment, Health & SafetyLeadership

173 more people are available in the full profile.

Premium access

Complete people profiles for Sterling Pharma Solutions

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Sterling Pharma Solutions

Sterling Pharma Solutions has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include ADC Biotechnology, CiVentiChem and NewChem Technologies.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
NewChem Technologies is an chemical company specializing in commercial applications for organic chemistry.
newchemtechnologies.comDurham, United Kingdom2002Oct 2023β€’β€’β€’β€’
Developer of antibody drug conjugate (ADC)
adcbio.comSaint Asaph, United Kingdom2010Apr 2021β€’β€’β€’β€’
Contract research and manufacturing services are offered for pharmaceuticals.
civentichem.comCary, United States1994Apr 2019β€’β€’β€’β€’
Premium access

Complete acquisition details for Sterling Pharma Solutions

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Sterling Pharma Solutions

6 dated milestones of Sterling Pharma Solutions across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Sterling Pharma Solutions is founded.
  2. Exit Acquired by GHO Capital Partners.
  3. Acquisition Acquires CiVentiChem.
  4. Acquisition Acquires ADC Biotechnology.
  5. Funding First funding round.
  6. Acquisition Acquires NewChem Technologies.

Web traffic of Sterling Pharma Solutions

The website of Sterling Pharma Solutions (sterlingpharmasolutions.com) receives about 12.2K visits a month and ranks #2,060,032 among all websites worldwide, #2,806 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    12.2K

    ▲ 6.4% vs previous month

  • Unique visitors
    4.6K

    per month

  • Global rank
    #2,060,032

    among all websites

  • Category rank
    #2,806

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Sterling Pharma Solutions. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
chiesiusa.com
chiesiusa.com
100%
#1,397,563–
rhoworld.com
81%
7.9K#2,859,814View details
novonordisk-us.com
78%
89K#469,241View details
catalent.com
78%
116.7K#338,870View details
ambiopharm.com
78%
15.1K#1,550,315View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 7 similar websites and full traffic analytics for Sterling Pharma Solutions

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 7 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Sterling Pharma Solutions

Premium access

Complete news archive for Sterling Pharma Solutions

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sterling Pharma Solutions

Sterling Pharma Solutions was founded in 2016 and raised its 1st funding round 7 years after it was founded.

Sterling Pharma Solutions is headquartered in Dudley, United Kingdom. It is registered at Dudley, West Midlands, United Kingdom.

Kevin Cook is the CEO of Sterling Pharma Solutions, as recorded in our data.

Sterling Pharma Solutions was established in 2016 in Dudley, United Kingdom. Operations focus on the pharmaceutical sector as a contract development and manufacturing organization (CDMO). Services encompass contract development, manufacturing, and analytical support specifically for active pharmaceutical ingredients (APIs). The company is led by CEO Kevin Cook and maintains its primary location in the UK to serve global clients in the industry.

Sterling Pharma Solutions offers API Development, API Manufacturing, ADC Development, Peptide Manufacturing, and Analytical Services.

Sterling Pharma Solutions has made 3 acquisitions, including ADC Biotechnology, CiVentiChem, and NewChem Technologies.

Sterling Pharma Solutions has 2 investors. Key investors include Partners Group, and GHO Capital.

Sterling Pharma Solutions operates through Sterling Pharma Solutions Limited.

Yes. Sterling Pharma Solutions was acquired by GHO Capital Partners in February 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available